Providence and Regence Reach Agreement

After a competitive selection process, we are pleased to announce the chief administrative officers (CAOs) for our Santa Rosa and Petaluma/Healdsburg medical centers.

​​​​​​​Ion robot-assisted bronchoscopy and Lung Nodule Clinic continue to ease patients’ way

Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.

The American College of Radiology (ACR) has once again awarded a three-year term of accreditation to the Providence Cancer Center for its radiation oncology program.

Jennifer Burrows, RN, has been chosen to serve as the chief executive of Providence Oregon.

Dr. Remi Ajiboye recently joined with a new partner, the state-of-the-art ExcelsiusGPS robotic navigation system. Here he talks about how it gives him an edge in patient care.

Carissa Silva has been named the new executive director of Strategy and Business Development for the Providence Alaska region.

Aortic stenosis is a condition in which blood flow out of the heart is obstructed, often leading to shortness of breath, chest pain, fatigue, leg swelling or even heart failure

Delivering state-of-the-art care in brand new NICU

Sprawling multi-million dollar facility in Orange County is a one-stop location to access full-suite of women’s health, mother-baby services and more

Discover leading-edge approaches for lasting relief.

Providence St. Jude Crosson Cancer Institute oncologists are aggressively pursuing new answers to metastatic prostate cancer, including research into an innovative immunotherapy called AMG 509.

When the SpaceX mission returns to earth in April, there will be 80 mice onboard who have spent a month living at the International Space Station. The rodents represent the first investigational ophth

Precision technology empowers early detection for improved patient outcomes

Margaret M. Horvath, FACHE, has been named executive director of Providence Alaska Children’s Hospital in Anchorage.

Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.